
OpGen OPGN
Quartalsbericht 2025-Q3
hinzugefügt 19.11.2025
OpGen P/E 2011-2025 | OPGN
P/E Jährlich OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.761 | -0.0613 | -0.01 | -0.0464 | -1.31 | -0.197 | -0.674 | -0.51 | -1.09 | -0.653 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.761 | -1.31 | -0.379 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 19.37 | - | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 21.18 | - | $ 228 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.24 | - | $ 7.04 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 39.4 | - | $ 1.09 B | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
39 | $ 230.32 | - | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.04 | - | $ 285 M | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.52 | - | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.57 | 0.03 % | $ 18.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
90.1 | $ 67.57 | - | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.72 | - | $ 808 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 19.48 | - | $ 1.05 B | ||
|
Celcuity
CELC
|
-3.57 | $ 102.25 | - | $ 4.03 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.2 | - | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 226.92 | - | $ 41.1 B | ||
|
Guardant Health
GH
|
-13.4 | $ 102.98 | - | $ 12.6 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.48 | - | $ 587 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 5.08 | 1.8 % | $ 2.73 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.13 | -0.14 % | $ 1.55 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.66 | - | $ 458 M | ||
|
Illumina
ILMN
|
-13.4 | $ 134.95 | - | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 203.66 | 0.25 % | $ 10.5 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 175.94 | - | $ 19.5 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.82 | - | $ 884 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 253.89 | -0.22 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 182.84 | -0.46 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 688.48 | - | $ 56.8 B | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.71 | - | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 420.1 | 0.21 % | $ 30.1 B | ||
|
Agilent Technologies
A
|
34.7 | $ 138.39 | - | $ 42.1 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.7 | - | $ 6.2 M | ||
|
Bioventus
BVS
|
-2.25 | $ 7.46 | 1.08 % | $ 467 M | ||
|
NeoGenomics
NEO
|
-19.4 | $ 12.28 | -0.16 % | $ 1.56 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.11 | - | $ 20 B |